Glycosinnovations Overview
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
Glycosinnovations General Information
Description
Developer of carbohydrate drugs designed to treat inflammatory and allergic diseases. The company's drugs are used in the treatment of asthma and allergic rhinitis, enabling healthcare providers to treat the patients and cure them.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
- Australia
Primary Industry
Drug Discovery
Corporate Office
- Australia
Glycosinnovations Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Secondary Transaction - Private | 01-Aug-2016 | Completed | Startup | |||
| 1. Early Stage VC | Completed | Startup |
Glycosinnovations FAQs
-
Where is Glycosinnovations headquartered?
Glycosinnovations is headquartered in Australia.
-
What industry is Glycosinnovations in?
Glycosinnovations’s primary industry is Drug Discovery.
-
Is Glycosinnovations a private or public company?
Glycosinnovations is a Private company.
-
What is Glycosinnovations’s current revenue?
The current revenue for Glycosinnovations is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process